Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 1130

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 14
Chunk 1130
---
 6, 2024, the Sponsor surrendered and forfeited 12,503,968 ordinary shares to the Company for no consideration, following which the Sponsor holds 9,857,143 ordinary shares (the “Founder Shares”). All share and per share data has been retrospectively presented. 

The accompanying notes are an integral part
of the financial statements.

F-5

DRUGS MADE IN AMERICA ACQUISITION CORP.

STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM MAY 23, 2024 (INCEPTION)
THROUGH DECEMBER 31, 2024

    Cash Flows from Operating Activities: 

    Net loss 
    $(279,845)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Operating costs paid through promissory note 
     30,300 
  
    Changes in operating assets and liabilities: 

    Accrued expenses 
     77,280 
  
    Net cash used in operating activities 
     (172,265)

    Cash Flows from Financing Activities: 

    Proceeds from issuance of Founder shares 
     35,000 
  
    Proceeds from promissory note - related party 
     1,802,648 
  
    Repayment of promissory note - related party 
     (1,300,433)
  
    Payment of offering costs 
     (363,599)
  
    Net cash provided by financing activities 
     173,616 

    Net Change in Cash 
     1,351 
  
    Cash – Beginning 
     — 
  
    Cash – Ending 
    $1,351 

    Non-cash investing and financing activities: 

    Offering costs included in accrued offering costs 
    $56,065 
  
    Deferred offering costs paid via promissory note – related party 
    $126,169 
  
    Prepaid services contributed by Sponsor through promissory note- related party 
    $3,640 

The accompanying notes are an integral part
of the financial statements.

F-6

DRUGS MADE IN AMERICA ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2024

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS

Drugs Made In America Acquisition Corp. (the “Company”)
is a blank check